Injective INJ
Current Price
$5.33 -9.90%
$0.6900 Daily Range (12.95%)
$5.30$5.99
$60.73M Daily Volume
700 BTC
Vol/MktCap: 11.39%
Market Performance
0.11% Relative BTC Volume
The total volume of Injective is $60.73M over the past 24 hours, compared to $54.59B total Bitcoin volume.
Hourly Moving Average
8 SMA $5.88 -9.37%
13 SMA $5.89 -9.49%
21 SMA $5.90 -9.59%
55 SMA $5.95 -10.44%
144 SMA $5.96 -10.51%
Price Performance
-8.90% 1 Hour Change
$5.33 from $5.85
-0.30% 7 Day Change
-$0.0159 from $5.35
-18.27% 14 Day Change
-$0.9739 from $6.30
-29.51% 30 Day Change
-$1.57 from $6.90
All Time High
March 14, 2024
$52.62 -89.86%
-$47.28 vs. now
24H Change
-58.63M USD -9.90%
-676 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
10.76M INJ
traded over past 24 hours
10.76% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $5.30, reflecting a significant 10.90% decline over the past 24 hours. The daily price range shows a high of $5.99 and a low of $5.30, indicating bearish pressure as the asset nears its lower boundary.
Volume stands at approximately 55.34 million, representing 10.44% of its market cap, suggesting moderate liquidity but a potential lack of buying interest at this level. The hourly moving averages indicate a persistent downward trend, with the 8, 13, 21, and 55 SMAs all showing declines between 9.88% and 10.94%.
The 1-hour RSI is at a critical level of 19, indicating extreme oversold conditions and potential for a short-term rebound. In contrast, the 7-day RSI of 47 suggests a neutral sentiment, but the recent price changes over 7, 14, and 30 days indicate a strong downtrend, with losses of 0.89%, 18.40%, and 30.15%, respectively.
Injective's all-time high of $52.62 reached in March 2024 highlights the significant distance from current levels, indicating that the asset is under considerable selling pressure. The continued decline may attract opportunistic traders, but the prevailing trend remains negative.
Given the current technical indicators and market conditions, a cautious approach is advised. The oversold RSI presents a possible short-term buying opportunity, but the overarching trend suggests further downside risk.
Rating: Hold. While the extreme oversold condition may offer a short-term bounce, the overall trend and significant losses over multiple time frames indicate that a more favorable entry point may be prudent.
Volume stands at approximately 55.34 million, representing 10.44% of its market cap, suggesting moderate liquidity but a potential lack of buying interest at this level. The hourly moving averages indicate a persistent downward trend, with the 8, 13, 21, and 55 SMAs all showing declines between 9.88% and 10.94%.
The 1-hour RSI is at a critical level of 19, indicating extreme oversold conditions and potential for a short-term rebound. In contrast, the 7-day RSI of 47 suggests a neutral sentiment, but the recent price changes over 7, 14, and 30 days indicate a strong downtrend, with losses of 0.89%, 18.40%, and 30.15%, respectively.
Injective's all-time high of $52.62 reached in March 2024 highlights the significant distance from current levels, indicating that the asset is under considerable selling pressure. The continued decline may attract opportunistic traders, but the prevailing trend remains negative.
Given the current technical indicators and market conditions, a cautious approach is advised. The oversold RSI presents a possible short-term buying opportunity, but the overarching trend suggests further downside risk.
Rating: Hold. While the extreme oversold condition may offer a short-term bounce, the overall trend and significant losses over multiple time frames indicate that a more favorable entry point may be prudent.
Updated 117 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Bitcoin Sentiment Sparks CZ Comment: Sell Greed, Buy Fear
Binance founder Changpeng Zhao’s blunt reminder about buying low and selling high landed at a tense time for crypto traders.

HyperLiquid team moves 2.6 mln HYPE – Panic buying or strategic play?
HyperLiquid’s $89.2M HYPE unstake sparks debate, but whale accumulation hints at strategic liquidity management.

Foreign Investors Set Record With $646.8 Billion in US Stock Purchases Amid Shifting Global Capital Flows
A powerful and unusual wave of global capital is rushing into US markets.

Binance Coin nears key liquidity zone as analysts see potential for major short squeeze
BNB is entering a crucial phase as analysts highlight key liquidity zones, stabilizing market cap, and emerging bullish momentum signals.